The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and

Insights

Poly (ADP-ribose) polymerase 7 (PARP7) regulates type I interferon (IFN-β) by modifying co-activators p300 and CBP. PARP7 inhibitors induce IFN-β via a dual mechanism involving both loss-of-function and gain-of-function effects.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Poly (ADP-ribose) polymerase 7 (PARP7) is a mono-ADP-ribosyl (MAR) transferase that suppresses type I interferon (IFN-β) in tumor cells.
  • PARP7 is a validated drug target, and its inhibitors increase IFN-β expression, but the precise mechanism remains unclear due to unknown substrates.

Purpose of the Study:

  • To identify nuclear substrates of PARP7 and elucidate the mechanism by which PARP7 inhibitors regulate IFN-β expression.

Main Methods:

  • Utilized an optimized analog-sensitive chemical genetic (ASCG) approach to identify PARP7 substrates.
  • Investigated the interaction between PARP7, p300, and CBP using biochemical and cellular assays.
  • Assessed the impact of disrupting PARP7-p300/CBP interaction on IFN-β expression in colorectal cancer cells.

Main Results:

  • Identified co-activators p300 and CBP as nuclear PARP7 substrates.
  • Discovered an α-helical domain in PARP7 crucial for p300/CBP interaction, MARylation, and proteasome degradation.
  • Demonstrated that disrupting PARP7-p300/CBP interaction inhibits PARP7's suppression of IFN-β.
  • Observed that PARP7 inhibitors induce IFN-β more effectively than PARP7 knockout in a p300/CBP-dependent manner.

Conclusions:

  • PARP7 regulates IFN-β by MARylating p300/CBP, and this interaction is essential for suppressing IFN-β in cancer cells.
  • PARP7 inhibitors induce IFN-β through a dual mechanism: inhibiting p300/CBP MARylation (loss-of-function) and stabilizing the PARP7-p300/CBP complex (gain-of-function).
  • These findings provide novel insights into the mechanism of PARP7 inhibitors and their potential in cancer immunotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K